“DAILY VERSUS ALTERNATE-DAY ROSUVASTATIN FOR DYSLIPIDEMIA: A RANDOMIZED CONTROLLED STUDY”. International Research Journal of Pharmacy, vol. 17, no. 3, Mar. 2026, pp. 1-11, https://doi.org/10.56802/e8qzhp89.